Cargando…

Corrigendum to: ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer’s disease and Alzheimer’s disease-related dementias clinical trials

Detalles Bibliográficos
Autores principales:	Jimenez-Maggiora, Gustavo A, Bruschi, Stefania, Qiu, Hongmei, So, Jia-Shing, Aisen, Paul S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867301/ https://www.ncbi.nlm.nih.gov/pubmed/35224459 http://dx.doi.org/10.1093/jamiaopen/ooac008

Ejemplares similares

ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer’s disease and Alzheimer’s disease-related dementias clinical trails
por: Jimenez-Maggiora, Gustavo A, et al.
Publicado: (2022)

Epigenetic mechanisms in Alzheimer’s disease [Corrigendum]
Publicado: (2014)

Speech and orofacial apraxias in Alzheimer's disease – CORRIGENDUM
por: Cera, Maysa Luchesi, et al.
Publicado: (2013)

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]
Publicado: (2014)

Corrigendum to “Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease”
por: Martín-Maestro, Patricia, et al.
Publicado: (2021)

Corrigendum: Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
Publicado: (2019)

Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
Publicado: (2021)

Corrigendum to “MUTYH Actively Contributes to Microglial Activation and Impaired Neurogenesis in the Pathogenesis of Alzheimer's Disease”
por: Mizuno, Yuri, et al.
Publicado: (2023)

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
Publicado: (2014)

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]
Publicado: (2021)

Literature Overview of the Relation Between Psoriasis and Alzheimer [Corrigendum]
Publicado: (2023)

Corrigendum to “Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges” [Redox Biol. 63 (2023) 102734]
por: Han, Ying, et al.
Publicado: (2023)

Corrigendum to “Contribution of Neurons and Glial Cells to Complement-Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease”
por: Luchena, Celia, et al.
Publicado: (2019)

PPARγ Agonist-Loaded PLGA-PEG Nanocarriers as a Potential Treatment for Alzheimer’s Disease: In vitro and in vivo Studies [Corrigendum]
Publicado: (2023)

Corrigendum to “Alzheimer's Disease Dementia as the Diagnosis Best Supported by the Cerebrospinal Fluid Biomarkers: Difference in Cut-Off Levels from Thai Experience”
por: Senanarong, Vorapun, et al.
Publicado: (2017)

Corrigendum to: Capillary Inward-Rectifying K(+) Channels Crippled in a Mouse Model of Alzheimer’s Disease: Phosphatidylinositol 4,5-Bisphosphate to the Rescue!
Publicado: (2021)

Corrigendum: Anodal transcranial direct current stimulation alleviates cognitive impairment in an APP/PS1 model of Alzheimer’s disease in the preclinical stage
Publicado: (2023)

Early-stage Alzheimer disease: getting trial-ready
por: Aisen, Paul S., et al.
Publicado: (2022)

[Corrigendum] Neuroprotective effect of emodin against Alzheimer’s disease via Nrf2 signaling in U251 cells and APP/PS1 mice
por: Li, Zhiping, et al.
Publicado: (2023)

Effects of Creative Expression Therapy for Older Adults with Mild Cognitive Impairment at Risk of Alzheimer’s Disease: A Randomized Controlled Clinical Trial [Corrigendum]
Publicado: (2023)

Corrigendum to “Helicobacter pylori infection contributes to the expression of Alzheimer's disease-associated risk factors and neuroinflammation” [Heliyon 9(9) (September 2023) e19607]
por: Noori, Maryam, et al.
Publicado: (2023)

Correction to: New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer’s disease
Publicado: (2018)

Topics in geometry: in memory of Joseph D'Atri
por: Gindikin, Simon
Publicado: (1996)

Corrigendum to “Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer's disease” [EBioMedicine 2 (2015) 294–305]
por: Zhang, Liang, et al.
Publicado: (2019)

Simvastatin inhibits the apoptosis of hippocampal cells in a mouse model of Alzheimer's disease
por: Hu, Xiaoqin, et al.
Publicado: (2018)

Whole‐exome sequencing in 20,197 persons for rare variants in Alzheimer's disease
Publicado: (2019)

Corrigendum to “Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH” [Neurosci. Lett. 533 (2013) 96–99]
por: Killick, R., et al.
Publicado: (2013)

Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”
por: Chen, Shuang, et al.
Publicado: (2018)

VCPA: genomic variant calling pipeline and data management tool for Alzheimer’s Disease Sequencing Project
por: Leung, Yuk Yee, et al.
Publicado: (2019)

Corrigendum to: Enhancing efficiency in a cardiac investigations department by increasing remote patient monitoring
por: Ryan, Paul, et al.
Publicado: (2020)

Recent developments in Alzheimer's disease therapeutics
por: Rafii, Michael S, et al.
Publicado: (2009)

Advances in Alzheimer’s Disease Drug Development
por: Rafii, Michael S, et al.
Publicado: (2015)

Alzheimer's disease therapeutic research: the path forward
por: Aisen, Paul S
Publicado: (2009)

Q & A: The Alzheimer's disease neuroimaging initiative
por: Aisen, Paul S
Publicado: (2011)

CORRIGENDUM: Impact of Mobile Cloud Electrocardiography System on Door-to-Balloon Time in Patients With Acute Coronary Syndrome in Oita Prefecture
por: Yufu, Kunio, et al.
Publicado: (2019)

Implementing electronic data capture (EDC) training for site staff
por: Webster-Smith, Mark, et al.
Publicado: (2015)

Corrigendum to “Dietary Lipids in Health and Disease”
por: Amin, Kamal A., et al.
Publicado: (2020)

Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease
por: Lambert, J-C, et al.
Publicado: (2013)

Corrigendum to “Plant-Derived Antioxidants in Disease Prevention”
por: Szymanska, Renata, et al.
Publicado: (2017)

Parkinson’s disease managing reversible neurodegeneration [Corrigendum]
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gb6mhmeibiv8r8e3lurcb7cit8